全文获取类型
收费全文 | 7822篇 |
免费 | 747篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 242篇 |
妇产科学 | 158篇 |
基础医学 | 902篇 |
口腔科学 | 218篇 |
临床医学 | 896篇 |
内科学 | 1741篇 |
皮肤病学 | 326篇 |
神经病学 | 584篇 |
特种医学 | 292篇 |
外科学 | 752篇 |
综合类 | 118篇 |
一般理论 | 4篇 |
预防医学 | 940篇 |
眼科学 | 176篇 |
药学 | 714篇 |
中国医学 | 5篇 |
肿瘤学 | 500篇 |
出版年
2021年 | 125篇 |
2020年 | 74篇 |
2019年 | 103篇 |
2018年 | 115篇 |
2017年 | 87篇 |
2016年 | 116篇 |
2015年 | 164篇 |
2014年 | 192篇 |
2013年 | 291篇 |
2012年 | 313篇 |
2011年 | 304篇 |
2010年 | 216篇 |
2009年 | 202篇 |
2008年 | 309篇 |
2007年 | 331篇 |
2006年 | 328篇 |
2005年 | 334篇 |
2004年 | 334篇 |
2003年 | 297篇 |
2002年 | 297篇 |
2001年 | 274篇 |
2000年 | 267篇 |
1999年 | 242篇 |
1998年 | 162篇 |
1997年 | 138篇 |
1996年 | 122篇 |
1995年 | 117篇 |
1994年 | 117篇 |
1993年 | 100篇 |
1992年 | 213篇 |
1991年 | 173篇 |
1990年 | 172篇 |
1989年 | 168篇 |
1988年 | 168篇 |
1987年 | 146篇 |
1986年 | 134篇 |
1985年 | 116篇 |
1984年 | 118篇 |
1983年 | 98篇 |
1982年 | 76篇 |
1981年 | 75篇 |
1980年 | 53篇 |
1979年 | 54篇 |
1978年 | 65篇 |
1976年 | 56篇 |
1975年 | 42篇 |
1974年 | 40篇 |
1973年 | 45篇 |
1972年 | 43篇 |
1968年 | 40篇 |
排序方式: 共有8598条查询结果,搜索用时 843 毫秒
1.
2.
3.
James R. Barrett MD Victoria Rendell MD Courtney Pokrzywa MD Alexandra G. Lopez-Aguiar MD John Cannon BA George A. Poultsides MD MS Flavio Rocha MD Angelena Crown MD Eliza Beal MD Timothy Michael Pawlik MD MPH PhD Ryan Fields MD Roheena Z. Panni MD MPHS Paula Smith MD Kamran Idrees MD Clifford Cho MD Megan Beems MD Shishir Maithel MD Sharon Weber MD Daniel Erik Abbott MD 《Journal of surgical oncology》2020,121(7):1067-1073
4.
D Monnier† C Vidal‡ L Martin§ A Danzon¶ F Pelletier† E Puzenat† MP Algros†† D Blanc† R Laurent† PH Humbert† F Aubin† 《Journal of the European Academy of Dermatology and Venereology》2006,20(10):1237-1242
BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a rare malignant tumour of the skin, with an estimated incidence of 0.8 to five cases per 1 million people per year. OBJECTIVE: To study epidemiological, immunohistochemical and clinical features, delay in diagnosis, type of treatment and outcome of DFSP from 1982 to 2002. METHODS: Using data from the population-based cancer registry, 66 patients with pathologically proved DFSP were included (fibrosarcomatous DFSP were excluded). Each patient lived in one of the four departments of Franche-Comté (overall population of 1 million people) at the time of diagnosis. The main data sources came from public and private pathology laboratories and medical records. The rules of the International Agency for Research on Cancer were applied. RESULTS: The estimated incidence of DFSP in Franche-Comté was about three new cases per 1 million people per year. Male patients were affected 1.2 times as often as female patients were. The trunk (45%) followed by the proximal extremities (38%) were the most frequent locations. DFSP occurred mainly in young adults between 20 and 39 years of age. Mean age at diagnosis was 43 years, and the mean delay in diagnosis was 10.08 years. Our 66 patients initially underwent a radical local excision. Among them, 27% experienced one or more local recurrences during 9.6 years of follow-up. There was one regional lymph node recurrence without visceral metastases. These recurrences were significantly related to the initial peripheral resection margins. We observed a local recurrence rate of 47% for margins less than 3 cm, vs. only 7% for margins ranging from 3 to 5 cm [P=0.004; OR=0.229 (95%, CI=0.103-0.510)]. The mean time to a first local recurrence was 2.65 years. Nevertheless, there was no death due to the DFSP course at the end of the follow-up, and the final outcome was favourable. CONCLUSION: Our study emphasizes the importance of wide local excision with margins of at least 3 cm in order to prevent local recurrence. However, the recent development of inhibitors of signal transduction by the PDGFB pathway should soon modify the surgical strategy, which is often too mutilating. 相似文献
5.
6.
The myopathies that can manifest themselves within the lower extremity are reported here and can serve as a guideline for clinicians in the early diagnosis of these disabling conditions. The classification of these disease entities based on signs and symptoms is significant if correlated with the age of the patient at the time of onset, the evolution and course, and the type of familial inheritance. This article can also aid the practitioner in assessing and planning the course of treatment for a particular patient. 相似文献
7.
8.
Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aorta 总被引:3,自引:3,他引:0 下载免费PDF全文
Bay K 8644 potentiated and augmented 5-hydroxytryptamine (5-HT)-induced contractions in the rabbit, isolated aorta preparation, as manifested in leftward shift and increase in the asymptote of 5-HT E/[A] (effect vs concentration) curves. The operational model of agonism (Black & Leff, 1983) was used to analyse this interaction and the concomitant effects of irreversible receptor alkylation by phenoxybenzamine. The competitive effects of spiperone in the presence and absence of Bay K 8644 were also examined. From these analyses it is concluded that Bay K 8644 elicits its potentiating effects by increasing the efficacy of 5-HT at the 5-HT2 receptor with no alteration in affinity. This is consistent with the known effect of Bay K 8644 of causing an increase in the functional concentration of plasmalemmal calcium channels coupled to the 5-HT2 receptors in this preparation. The positively co-operative shape of the 5-HT E/[A] curves obtained in the aorta and the quantitative nature of their potentiation by Bay K 8644 indicated that the coupling of 5-HT2 receptor occupancy to intracellular calcium concentration is linear and that the co-operativity resides in the subsequent relation between intracellular calcium and pharmacological effect. Bay K 8644 may serve as a probe for differentiating between the types of calcium channels that transduce 5-HT receptor-mediated effects in different systems. Such information would be useful in the classification of agonist interactions with 5-HT receptors. 相似文献
9.
10.
L. TIMMER-DE MIK M.D. D.M. BROEKHUIJSEN-VAN HENTEN M.D. † J.M. OLDHOFF M.D. PH.D. D.B. DE GEER M.D. ‡ V. SIGURDSSON M.D. PH.D. S.G.M.A. PASMANS M.D. PH.D. 《Pediatric dermatology》2009,26(3):358-360
Abstract: In Sweet's syndrome, the essential features are the characteristic morphology of the lesions, their histologic appearance, the dramatic response to corticosteroids and the absence of scarring. We report an 8-month-old infant in whom Sweet's syndrome was diagnosed and who developed acquired cutis laxa in the skin lesions. 相似文献